Icon

JEVTANA KIT (nda201023)- (60MG/1.5ML (40MG/ML))

CABAZITAXEL SANOFI AVENTIS US
60MG/1.5ML (40MG/ML)
Yes No
2031-Apr-27 Expired
None None
None No
JEVTANA is a microtubule inhibitor indicated in combination with prednisone for treatment of patients with metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing treatment regimen.
5 2 0
Total Other Developers None
Drugs with Suitability No
60MG/1.5ML (40MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.